[{"NetIncomeLoss_1_Q2_USD":-30842000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":15.84,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-59000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":173100000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":46400000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.0111,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q2_pure":0.0111,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":980000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":123798000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":123798000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1597040.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-67000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-34000.0,"AssetsCurrent_0_Q2_USD":371818000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":163460000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q2_pure":0.888,"DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_2_Q2_pure":0.5,"DueToRelatedPartiesCurrent_0_Q2_USD":11396000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":2563000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":1247000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":165080000.0,"CommonStockSharesIssued_0_Q2_shares":47525560.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_2_Q2_USD":4651000.0,"Assets_0_Q2_USD":404232000.0,"ShareBasedCompensation_2_Q2_USD":6596000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":4349000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":16.66,"OtherAccountsPayableAndAccruedLiabilities_0_Q2_USD":20096000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":123995000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":9260957.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.902,"AccruedLiabilitiesCurrent_0_Q2_USD":20096000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"ResearchAndDevelopmentExpense_2_Q2_USD":50677000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":26432000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":15.84,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-74000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-136000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-57000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":null,"DepreciationDepletionAndAmortization_2_Q2_USD":365000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":126369000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-54927000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-30868000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":3780000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":192412000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":3691000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":696157000.0,"DueFromRelatedPartiesCurrent_0_Q2_USD":7077000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":44864637.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":44546172.0,"GeneralAndAdministrativeExpense_1_Q2_USD":6715000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":12680000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":12.39,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":19.79,"MarketableSecuritiesCurrent_0_Q2_USD":161868000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":8000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-20000.0,"DefinedContributionPlanCostRecognized_1_Q2_USD":0.0,"DefinedContributionPlanCostRecognized_2_Q2_USD":200000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":2563000.0,"Liabilities_0_Q2_USD":46785000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1421000.0,"IncreaseDecreaseInAccountsPayableTrade_2_Q2_USD":4874000.0,"CommonStockSharesAuthorized_0_Q2_shares":90000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-87000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-26000.0,"DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_2_Q2_USD":3500.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-54840000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-30842000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":6596000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3936000.0,"IncreaseDecreaseInAccountsPayableRelatedParties_2_Q2_USD":8664000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-52456000.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":26122000.0,"LiabilitiesCurrent_0_Q2_USD":42973000.0,"AccountsPayableCurrent_0_Q2_USD":7905000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":192637000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":7683000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.88,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q2_pure":0.88,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":511000.0,"NetIncomeLoss_2_Q2_USD":-54840000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1718000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":96800000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":63000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"OperatingLeasePayments_2_Q2_USD":987000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":5961336.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q2_pure":0.0085,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.0011,"CashEquivalentsAtCarryingValue_0_Q2_USD":185000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":173100000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q2_pure":0.21,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":177152.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-12468000.0,"RestrictedCashNoncurrent_0_Q2_USD":225000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":74819000.0,"OperatingIncomeLoss_2_Q2_USD":-54903000.0,"OperatingIncomeLoss_1_Q2_USD":-30882000.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_2_Q2_USD":1386000.0,"StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_2_Q2_shares":106672.0,"ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_2_Q2_USD":1500000.0,"ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_1_Q2_USD":400000.0,"IncomeTaxesReceivable_0_Q2_USD":2778000.0,"IncreaseDecreaseInIncomeTaxesReceivable_2_Q2_USD":1682000.0,"InvestmentIncomeInterest_2_Q2_USD":199000.0,"InvestmentIncomeInterest_1_Q2_USD":97000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":2009000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":26.97,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":11.54,"LiabilitiesAndStockholdersEquity_0_Q2_USD":404232000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":6596000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-338651000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":2980187.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":5961336.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-821000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":640000.0,"StockholdersEquity_0_Q2_USD":357447000.0,"CommonStockSharesOutstanding_0_Q2_shares":47525560.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":121000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.69,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.23,"OperatingExpenses_1_Q2_USD":33147000.0,"OperatingExpenses_2_Q2_USD":63357000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1567000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3936000.0,"ProfitLoss_2_Q2_USD":-54840000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":829000.0,"Ticker":"PTGX","CIK":"1377121","name":"PROTAGONIST THERAPEUTICS, INC","OfficialName":"Protagonist Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"939483174.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210804"}]